author-photo

Beatrice Seddon

University College Hospital

83

Papers

3262

Citations

Citation Trend

Filter By

Papers (64) Sort By

Journal Conference Others

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113).

2020 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (2)
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

2019 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (39)
Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor

2019 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (13)
IMRiS phase II study of IMRT in limb sarcomas: Results of the pre-trial QA facility questionnaire and workshop

2019 Radiography
Show All
- Source
- Cite
- Save
Citations (0)
Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood

2018 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (3)
OC-0449: A novel and objective plan evaluation for limb sarcomas IMRT in the IMRiS phase II trial

2017 Radiotherapy and Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Can postoperative radiotherapy be omitted in localized standard-risk Ewing sarcoma? An observational study of the Euro-EWING Group.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
Abstract 5029: Pharmacogenetics of doxorubicin, gemcitabine and docetaxel in the GeDDiS soft tissue sarcoma trial

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

2017 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (184)
Activity of cediranib in alveolar soft part sarcoma (ASPS) confirmed by CASPS (cediranib in ASPS), an international, randomised phase II trial (C2130/A12118).

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (14)